AA
AlphaCentric Advisors’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $269K | Sell |
2,211
-15,789
| -88% | -$1.92M | 0.27% | 97 |
|
|
2024
Q3 | $2.25M | Buy |
18,000
+10,500
| +140% | +$1.31M | 1.67% | 12 |
|
|
2024
Q2 | $1.19M | Buy |
7,500
+7,231
| +2,688% | +$1.14M | 0.87% | 39 |
|
|
2024
Q1 | $34.8K | Sell |
269
-36
| -12% | -$4.66K | 0.02% | 223 |
|
|
2023
Q4 | $29.4K | Sell |
305
-31
| -9% | -$2.99K | 0.02% | 211 |
|
|
2023
Q3 | $40.7K | Sell |
336
-57
| -15% | -$6.91K | 0.02% | 223 |
|
|
2023
Q2 | $45K | Buy |
+393
| New | +$45K | 0.03% | 228 |
|
|
2021
Q4 | $540K | Sell |
6,000
-3,000
| -33% | -$270K | 0.16% | 60 |
|
|
2021
Q3 | $832K | Sell |
9,000
-5,000
| -36% | -$462K | 0.21% | 41 |
|
|
2021
Q2 | $1.09M | Buy |
14,000
+4,500
| +47% | +$350K | 0.3% | 19 |
|
|
2021
Q1 | $708K | Buy |
9,500
+8,775
| +1,210% | +$654K | 0.24% | 33 |
|
|
2020
Q4 | $124K | Buy |
725
+550
| +314% | +$94.1K | 0.05% | 101 |
|
|
2020
Q3 | $25K | Buy |
+175
| New | +$25K | 0.01% | 137 |
|